All In Biotech

Free tool

FAERS Monitor: Injectafer

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 203565 or its brand name (Injectafer, Ferric Carboxymaltose). Reports on generic versions are filed under their own applications.

Reports

4,728

Serious

2,512

53% of reports

Hospitalization

638

Death reported

90

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • hypophosphataemia871
  • nausea553
  • pain430
  • dyspnoea399
  • headache370
  • product quality issue326
  • dizziness310
  • anxiety293
  • urticaria288
  • arthralgia280
  • emotional distress259
  • pruritus256
  • anhedonia254
  • blood phosphorus decreased233
  • asthenia216

Reports by year received

View as table
YearReports
20133
201445
2015170
2016205
2017395
2018473
2019656
2020525
2021578
2022628
2023352
2024252
2025257
2026189

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,431 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hypophosphataemiaSignal871593.8556.6454,462
blood phosphorus decreasedSignal233302.8266.065,349
anhedoniaSignal25443.438.510,392
product quality issueSignal32610.79.62,869
emotional distressSignal2599.58.51,977
urticariaSignal2887.76.81,671
anxietySignal2934.64.1828
dyspnoeaSignal3993.12.9594
painSignal4303.12.8634
nauseaSignal5533.12.9820
arthralgiaSignal2803.02.7378
pruritusSignal2563.02.6337
dizzinessSignal3102.82.5356
headacheSignal3702.62.4382
astheniaSignal2162.62.2207

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.